Data from: Loss of miR-143 and miR-145 in condyloma acuminatum promotes cellular proliferation and inhibits apoptosis by targeting NRAS
收藏DataONE2018-08-10 更新2024-06-08 收录
下载链接:
https://search.dataone.org/view/null
下载链接
链接失效反馈官方服务:
资源简介:
The expression profile of miRNAs and their function in condyloma acuminatum (CA) remains unknown. In this study, we aimed to detect the effects of miR-143 and miR-145, the most downregulated in CA samples using high-throughput sequencing, on cell proliferation and apoptosis, to determine a novel therapeutic target for CA recurrence. RT-qPCR was used to validate the lower expression of miR-143 and miR-145 in a larger size of CA samples, and the expression of NRAS in CA samples was significantly higher than self-controls as determined western blotting assay. Luciferase assay was performed to confirm that miR-143 or miR-145 targeted NRAS directly. Transduction of LV-pre-miR-143 or LV-pre-miR-145 to human papilloma virus (HPV)-infected SiHa cells led to reduced proliferation, greater apoptosis, and inhibition of expression of NRAS, PI3Kp110α, and pAKT. However, knockout of miR-143 or miR-145 in human epidermal keratinocytes (HEKs) by delivery of CRISPR/CAS9-gRNA for target miRNAs protected cells from apoptosis and upregulated expression of target genes as described above. MiR-143 and miR-145 sensitized cells to nutlin-3a, a p53 activator and MDM2 antagonist, while their loss protected cells from the stress of nutlin-3a. Furthermore, siRNA targeting NRAS showed similar effects on proliferation and apoptosis as miR-143 or miR-145. Taken together, our results suggest that loss of miR-143 or miR-145 in CA protects HPV-infected cells from apoptosis induced by environmental stress, in addition to promoting cellular proliferation and inhibiting apoptosis by targeting NRAS/PI3K/ATK. Restoration of miR-143 or miR-145 might provide an applicable and novel approach to block the recurrence and progression of CA.
尖锐湿疣(condyloma acuminatum, CA)组织中微小RNA(microRNA, miRNA)的表达谱及其功能尚未明确。本研究旨在探究经高通量测序筛选得到的CA样本中下调最为显著的miR-143与miR-145对细胞增殖与凋亡的调控作用,以期为CA复发探寻全新的治疗靶点。我们采用实时定量聚合酶链式反应(RT-qPCR)在更大样本量的CA组织中验证了miR-143与miR-145的低表达水平;同时通过蛋白质印迹实验发现,CA样本中NRAS的表达量显著高于自身对照样本。双荧光素酶报告基因实验证实,miR-143或miR-145可直接靶向NRAS。将携带pre-miR-143或pre-miR-145的慢病毒(LV)转染人乳头瘤病毒(HPV)感染的SiHa细胞后,细胞增殖能力降低、凋亡水平显著升高,且NRAS、PI3Kp110α及pAKT的表达受到明显抑制。而通过CRISPR/CAS9-gRNA系统靶向敲除人表皮角质形成细胞(HEKs)中的miR-143或miR-145,则可使细胞抵抗凋亡,并上调上述靶基因的表达。miR-143与miR-145可增强细胞对nutlin-3a(一种p53激活剂与MDM2拮抗剂)的敏感性,而二者的敲除则可使细胞免受nutlin-3a诱导的应激损伤。此外,靶向NRAS的小干扰RNA(siRNA)可产生与miR-143或miR-145类似的增殖与凋亡调控效应。综上,本研究结果表明,CA组织中miR-143或miR-145的缺失,不仅可通过靶向NRAS/PI3K/AKT通路促进细胞增殖、抑制凋亡,还可使HPV感染的细胞免受环境应激诱导的凋亡。恢复miR-143或miR-145的表达,或许可为阻断CA的复发与进展提供一种可行的全新治疗策略。
创建时间:
2018-08-10



